| Accession Number | 0000785161-26-000158 |
|---|---|
| Form Type | 4 |
| Filing Date | May 18, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Financial Officer | Encompass Health Common Stock | โ | May 15, 2026 | Exercise/Conversion | 27,694 | $32.94 | $912,240.36 | 97,071 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Encompass Health Common Stock | โ | May 15, 2026 | Sale | 27,693 | $106.83 | $2,958,443.19 | 69,378 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Encompass Health Common Stock | โ | May 15, 2026 | Sale | 1 | $107.28 | $107.28 | 69,377 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Non-qualified Stock Option (Right to Buy) | Derivative | May 15, 2026 | Exercise/Conversion | 27,694 | $0.00 | $0.00 | 0 | Direct | โ | View Details |